Antimicrobial Peptides: A Roadmap for Accelerating Discovery and Development

About

Luis H. Reyes is an Associate Professor at Universidad de Los Andes (Bogotá Colombia) and Director of the Product and Process Design Group. Luis is a chemical engineer (Universidad Industrial de Santander Colombia) with a PhD. in Chemical Engineering from Texas A&M University (College Station TX USA). His research interest focuses on applying biological engineering to design and develop bioprocesses and bioproducts using various tools borrowed from the natural sciences such as molecular and synthetic biology reverse engineering of microorganisms laboratory adaptive evolution and microbiology. He teams with an interdisciplinary research group in the biomedical engineering area to develop bionanoconjugated vehicles to transport and deliver biological molecules with therapeutic potential including gene and enzyme replacement therapies. He also works in the discovery and production of peptides with applications in the medical food and petrochemical industries. In food engineering Luis studies the sensory design of beer and the protein replacement of dairy products. Juan Carlos Cruz obtained his undergraduate degree in Chemical Engineering from the National University of Colombia (2002) and later his Ph.D. in Chemical Engineering from Kansas State University (KSU) (2010) for his work on a new platform for enzyme immobilization to address biocatalysis challenges in non-aqueous media. Cruz has experience as Head of New Product Development in a chemical company where he developed several nanotechnological applications to improve critical attributes of plastics according to the requirements and standards of new market niches. In 2016 he joined the Department of Biomedical Engineering at Universidad de Los Andes (Bogotá Colombia). Cruz has more than fifteen years of working in the fields of industrial and medical biotechnology and in particular in the development of nanobiocatalysts the fundamental understanding of protein-protein protein-surface and protein-lipid interactions the development of new nanoparticulate vehicles for the release and guidance of pharmacological molecules and the search for unique peptides with membrane activity. Gregory R. Wiedman works at Seton Hall University in NJ USA.